Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/AHRQ collaboration

Executive Summary

ODS Deputy Director Anne Trontell will embark on a year-long FDA-sponsored detail beginning in mid-January as a senior advisor in pharmaceutical outcomes research for the Agency for Healthcare Research & Quality. The move will help to improve understanding of the health outcomes of marketed drugs, FDA says, noting the collaboration is part of an effort to foster research partnerships on drug effectiveness and safety. Trontell will promote collaborative research between FDA, AHRQ, CMS, and professional and academic institutions. Office of Pharmacoepidemiology and Statistical Science Deputy Director Jonca Bull will serve as acting ODS deputy director...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS046704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel